Salem Investment Counselors Inc Armata Pharmaceuticals, Inc. Transaction History
Salem Investment Counselors Inc
- $3.24 Billion
- Q3 2024
A detailed history of Salem Investment Counselors Inc transactions in Armata Pharmaceuticals, Inc. stock. As of the latest transaction made, Salem Investment Counselors Inc holds 100 shares of ARMP stock, worth $220. This represents 0.0% of its overall portfolio holdings.
Number of Shares
100
Previous 100
-0.0%
Holding current value
$220
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ARMP
# of Institutions
27Shares Held
1.38MCall Options Held
400Put Options Held
17.3K-
Bank Of America Corp Charlotte, NC634KShares$1.39 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA225KShares$495,6310.0% of portfolio
-
Geode Capital Management, LLC Boston, MA107KShares$235,5450.0% of portfolio
-
Edgewood Management LLC Greenwich, CT100KShares$220,0000.0% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX75.4KShares$165,8400.0% of portfolio
About Armata Pharmaceuticals, Inc.
- Ticker ARMP
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,144,700
- Market Cap $79.5M
- Description
- Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus ...